- Home
- PRPL vs KPTI Comparison
PRPL vs KPTI Comparison
Compare PRPL & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRPL | KPTI |
|---|---|---|
| Founded | 2010 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.1M | 194.8M |
| IPO Year | 2015 | 2013 |
Fundamental Metrics
Financial Performance| Metric | PRPL | KPTI |
|---|---|---|
| Price | $8.00 | $7.08 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $0.65 | ★ $16.00 |
| AVG Volume (30 Days) | 211.9K | ★ 554.0K |
| Earning Date | 04-28-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 152.75 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $468,725,000.00 | $146,067,000.00 |
| Revenue This Year | $8.50 | N/A |
| Revenue Next Year | $6.68 | $22.36 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 0.57 |
| 52 Week Low | $0.28 | $3.65 |
| 52 Week High | $8.50 | $10.99 |
Technical Indicators
Market Signals| Indicator | PRPL | KPTI |
|---|---|---|
| Relative Strength Index (RSI) | 94.79 | 31.80 |
| Support Level | $0.54 | $6.91 |
| Resistance Level | N/A | $7.59 |
| Average True Range (ATR) | 0.38 | 0.75 |
| MACD | 0.76 | -0.30 |
| Stochastic Oscillator | 93.80 | 14.04 |
Price Performance
Historical ComparisonAbout PRPL Purple Innovation Inc.
Purple Innovation Inc designs and manufactures sleep products. Using its GelFlex Grid technology, the company designs, manufactures, and offers branded comfort sleep products, including mattresses, pillows, cushions, mattress protectors, bases, sheets, and others. It markets and sells these products through direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).